chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On June 12, 2022, I got really sick and had a bladder infection. Two days later, I went to the ER because I thought I was having a heart attack and they diagnosed me with pneumonia. They said that they thought it looked like COVID pneumonia and I've never had pneumonia before. They tested me for COVID-19, and I was negative. My blood oxygen level was also at 90 and they advised that if it got any lower to come back. The bottom of my left lung is missing due to a surgery that I had many years ago, so I believe that I may have been affected more harshly than others may have been. I've been monitored closely by my doctor since these events. As of 08/10/2022, I am still on an antibiotic. I have been prescribed multiple antibiotics over this span of time since none have been able to get rid of the white blood cells that were discovered on a uranalysis that cannot be explained.
Re-infected with Covid 6/8/2021 Admitted to ICU 6/12/21 for shortness of breath and hypoxia, gastroenteritis  Treating with Remdesivir and solumedrol
11April96 Pt recv 1 dose vax. No concomitant med. 21Dec97 Pt exp full-blown chickenpox w/classic varicella lesions on stomach,trunk,face,legs & arms. 101 fever. 23Dec97 Pt to MD. Tx w/Benadryl) & Aveeno bath.Pt recovered 01Jan98.04111996
The day after receiving Arexvy the patient reported tongue swelling, inability to swallow and rash.  The patient went to the hospital where she was treated and sent home.
This case was reported by a nurse via sales rep and described the occurrence of adverse drug reaction in a female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse drug reaction and activities of daily living impaired. On an unknown date, the outcome of the adverse drug reaction and activities of daily living impaired were unknown. It was unknown if the reporter considered the adverse drug reaction and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The physician (patient) experienced some unexpected side effects after immunization with SHINGRIX recently and it did affect her ability to carry out daily activities for a couple of days. The reporter think that she was having second thoughts about getting the second dose. The reporter sent the product information (PI) to the patient, which did mention that the 2nd side effects are sometimes worse than the dose 1st, but the reporter also know that its better protection with a completed 2nd dose series. This might be something that the reporter need to counsel patients about in a very deliberate way, especially those younger than 70 years.
Information has been received from a nurse referring to a patient of unknown age and gender. Information about concomitant therapy, concurrent condition, drug reactions/allergies and medical history was not provided. On 08-NOV-2018, the patient received two vaccines via the intramuscular route instead of the subcutaneous route. The two vaccines were M-M-R II (lot # N023149, expiration date was 24-AUG-2019, indication: prophylaxis, strength was not reported) and VARIVAX (lot # N034559, expiration date was 05-DEC-2019, indication: prophylaxis, strength was not reported). No adverse effects were reported in the patient.
Patient fainted approximately 10 minutes after vaccination. Pt vomited and soiled herself. She recovered quickly and denied our offer to call EMS
Arm began itching 24 hrs post vaccination with progressive redness, swelling, and warmth 48 hrs post vaccination
Achy, tired, fever, chills, sore arm. Took ALEVE.
Fatigue; This is a spontaneous report from a non-contactable other healthcare professional. A female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. It was unknown if the patient was pregnant. Medical history and concomitant medications were not reported. On an unknown date, the patient experienced fatigue. The clinical outcome of the event fatigue was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
05/04/05- onset of over 60 papules, no fever. Upper torso to legs, itchy. In contact with classmate with chicken pox disease.
Very tired - 4 hours after - It has been 5 days - still very tired Nausea started 48 hours after still have it 5 days later.  Fever 12 hours later - lasted about 6 hours Body aches 12 hours later lasted for about 36 hours Headache 12 hours later lasted about 36 hours
pt recv vax 15JUL96 late AM & w/in 2 1/2hr post vax pt was taken to clinic exp sz activity w/t103;w/u completed & d/c that same day ;16JUL MD spoke w/mom sx improved;18JUL f/u in clinic resolved-t98.7, fussy-no other;
Heart attack.  2 stents placed.  Meds administered x1 year +.
Vomiting x1 day after, next day had a drooping eyelid and difficulty chewing/swallowing.  Four days after vaccine had aphasia and then went to ED.  Diagnosed with Bell's palsy.
vials WERE ALSO AFFECTED BY A TEMPERATURE EXCURSION; The vial was stroed in refrigrator on 13-sep-2022 and adminstered on 10-Nov-2022; No adverse event; 3 infant patients received doses after the beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 infant patients received doses after the beyond use date), PRODUCT TEMPERATURE EXCURSION ISSUE (vials WERE ALSO AFFECTED BY A TEMPERATURE EXCURSION), PRODUCT STORAGE ERROR (The vial was stroed in refrigrator on 13-sep-2022 and adminstered on 10-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an infant patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 infant patients received doses after the beyond use date). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (vials WERE ALSO AFFECTED BY A TEMPERATURE EXCURSION), PRODUCT STORAGE ERROR (The vial was stroed in refrigrator on 13-sep-2022 and adminstered on 10-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (3 infant patients received doses after the beyond use date), PRODUCT TEMPERATURE EXCURSION ISSUE (vials WERE ALSO AFFECTED BY A TEMPERATURE EXCURSION), PRODUCT STORAGE ERROR (The vial was stroed in refrigrator on 13-sep-2022 and adminstered on 10-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (3 infant patients received doses after the beyond use date), PRODUCT TEMPERATURE EXCURSION ISSUE (vials WERE ALSO AFFECTED BY A TEMPERATURE EXCURSION) and PRODUCT STORAGE ERROR (The vial was stroed in refrigrator on 13-sep-2022 and adminstered on 10-Nov-2022).    No concomitant medication were reported.  It was reported that vials were affected by a temperature excursion and compliance inspector wanted to report and asked for an assessment in regards to pediatric patients (6 months to 5 years old) who received doses of the Monovalent Moderna COVID19 vaccine after the beyond use date. HCP wanted to know if the patients should be revaccinated or not. Dose were administered after 30-day use by date. Individual vials or unbroken cartons were stored in the box. Vial size was unknown to the reporter. The vial was initially stored in the refrigerator on 13-Sep-2022. The vial underwent temperature excursions and during excursion vials were stored in refrigerator. Maximum or minimum temperatures reached was 6-degree Fahrenheit and 45.3 degree Fahrenheit. Excursion duration was 2 hours and 21 minutes. Vails were maintained in fridge.  No treatment medication were reported.
Left side area of spleen, splenomagaly to palpation. Dull ache, increased pain on inspiration, sharp pain to palpation.
2nd dose less than 4 weeks apart from 1st dose; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 4-year-old male patient who received Flu Seasonal QIV (FluLaval Quadrivalent 2021-2022 season) (batch number J7C77, expiry date 26th February 2023) for prophylaxis.   Co-suspect products included flu seasonal qiv pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included INFLUENZA VACCINE INACT (FLULAVAL QUADRIVALENT).   On an unknown date, the patient received the 2nd dose of FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 20-Sept-2022 Reporter's comment: The patient received 2nd dose of flulaval less than 4 weeks apart from the 1st dose. The reporter consented to follow-up.  Additional supportive information: The patient received 2nd dose of Flulaval earlier than the recommended interval, which led to shortening of vaccine schedule.
pt recvd 2nd dose of vax & devel burning sensation w/soreness &/or aching  in arm; sensation persisted assoc w/ a feeling of heaviness in the arm which lasted x 24 hrs; pt denied fever, local swelling or erythemia
Couple of days after my first dose, I noticed a ringing in my ears. It lasted for some days; I took some ibuprofen and went to sleep. I woke up pretty nauseous and fatigue. I brushed it off until I received my second dose. I had extreme nausea and it coupled with facial flushing. It was happening every other day; some days it would last the whole day. Anti-nausea didn't help settle the discomfort or anything. The ringing in my ears came back and reduced after about a week or so. I contacted my doctor, about the nausea and he prescribed me Zofran to help settle it. Eventually, everything settled and became tolerable. It never really went away; after receiving my booster shot on 12/22/2021, it heightened and became even worse again. The ringing in my ears and nausea became worse again and still hasn't settled since then.
Patient felt extremely ill the day after receiving the shot. Her main complaint is nausea. This resolved after a few days, but patient did visit her physician.
When presenting to COVID vaccine clinic, patient reported a significant allergic reaction to dose 1 of the COVID vaccine. She reported SOB, itching, throat tightness. Was placed on steroids to remedy the reaction. Advised to not receive dose 2. She was in agreement to this plan.
First I felt a general malaise or exhaustion and then I had a fever. It was the worst I have never been that sick when I have had the flu or sick for that long, I took Tylenol cold am pm meds, I slept 4 days. I had sweats and chills. I felt fatigued for a while, even after my quarantine. I had post external malaise.
Herpes outbreak (Flare-up).  It had been over a year since having my last flare.  1 lesion on the 24th. There was no sign that this was coming on, (itching or pain) and then the 2nd lesion came out on the 25th.  I didn't take my valtrex when this happen because I was afraid that the anti-viral medicine  would weaken my immunity process for the covid.  Usually I know a couple days ahead of time that I'm getting ready to flare.  This time was different it just popped out with no warning. Still going through this due to not taking medicine.  My doctor won't be back in office until Monday 3/29. If it is not better by then I will call my doctor.
I caught COVID-19. On the morning of 7/8/2022  I started to feel kind of dizzy and foggy. I took a nap, and then when I woke up I noticed that I had a fever. It was at 100 degrees and then it went up to 102 degrees the following 3 nights in a row. I was sleeping a lot. My heartrate was high and close to 100 beats per minute. My normal heartrate is about 67 beats per minute, but at resting my heartrate was at 90 beats per minute. I went to urgent care. I got a prescription for an inhaler and a cough depressant, but I didn't use it because I wasn't having issues breathing and I wasn't coughing. I was taking Benadryl decongestant. My fever broke yesterday morning. I'm still having after effects of a sinus infection. I am still not completely well.
After I drove up and got my shot, the people had me drive to the next parking lot and park.  We had to park every other space.  By the time I got parked, I started to feel dizzy.  I was afraid to tell anyone because I didn't want to go to the hospital.  At first, I felt extremely dizzy so that I would not have driven if I had been allowed.  Then, My heart then started to race for about 5 minutes before it started to calm down.  The person who gave me my shot wrote on my paper on my dashboard that I had to sit for 20 minutes after my shot.   I sat there for the whole 20 minutes and by the time I left, I felt much better, but it scared me it a bit.  I was told to beep my horn if I had a reaction, but I was afraid too.  I sat in my truck and waited to see if it got better or worse.  It did get better.  I was told by friends that I should report it so I am. I have been fine this week since that happened after the vaccination, without any dizziness or heart racing.  But, I am having pain in my left leg and I'm a little worried about that because people are reporting blood clots.  I think I have a vein that is bad in that leg, although I have never been diagnosed with it.   That area has caused me pain in the past but I am so used to it that I normally just ignore it.  There's just a spot on my left thigh that hurts where I think the veins are bad.  Since the vaccination, I have had more pain in that area.  I don't know if I need to be concerned with that.  I have been trying to wait that out too.
Patient with history of breast cancer and lymphoma. She was seen in the ED on 1/5/23 for a breathing problem - she reported she had been coughing a lot and could barely catch her breath. This had been going on for about a month, and her symptoms had been progressively worsening. A COVID PCR test done in the ED resulted negative. Initially she was admitted 1/5/23 for sepsis due to multifocal community-acquired pneumonia and acute respiratory failure with hypoxia. On room air, SPO2 was 88%, and improved to 90% after being placed on 1-2L nasal cannula. Severe sepsis, acute hypoxemic respiratory failure eventually resolved after patient completed antibiotic treatment. On 1/17, a bronchoscopy was performed, and a right lower lobe BAL specimen was sent for respiratory panel, PCR. This returned positive for SARS-CoV-2. Patient was discharged 1/23/23 with discharge diagnoses including severe sepsis due to multifocal community-acquired pneumonia and acute respiratory failure with hypoxia, as well as moderate to severe COVID-19 and COVID pneumonia, among other diagnoses. Patient has received the primary COVID vaccine series and two boosters.
During preemployment screen, antibody testing was done Rubeola (NR). Vaccinated with MMR. Returned to office on 5/30/03 and advised. She is 7 weeks pregnant. She will advise of pregnancy progression. (Measles vaccine is not available).
I had low blood sugar after 45 minutes after dose 1.  Orange juice and cracker fixed that issue. a week later I developed a Covid arm , it was itchy painful and it burned. I had swelling and it was really hot to the touch and hard. 3 weeks after the first dose I developed allergies and they were non stop , with congestion and I had headaches  I didn't take any medication.  I recovered from the covid arm , but not the allergies.
Patient recived vaccines and fainted on the parking lot. He lost consciousness and bump his head on the paviment. 911 was called and he was transported to hospital.
Two days after receiving my second shot(Monday) I began feeling extremely nauseous around 4am early Thursday morning. I vomited on and off until 8 am, feeling extremely dizzy and uneasy the whole time. I finally went to urgent care when they opened at 8 and got fast acting anti nausea pills which helped temporarily. It began again early Friday morning around the same time. At this point I felt so dizzy that I may pass out, i was dehydrated from vomiting bile the previous day, so by 6 am I went to the ER for fluids and IV anti nausea meds.  I remained somewhat nauseous and could not eat solid food until Saturday night. I woke up Sunday morning still feeling weak and a little nauseous. As of Sunday night, writing this, I feel very nauseous and dizzy again and took Pepto, Dramamine, and turmeric to combat it. It should be noted that I began my period Wednesday when the symptoms started and I worry that my hormones affected my symptoms.
Pt with known anaphylaxis with prior Flu Shots x 2. Pt received COVID vaccine, dose #1 at 10:30am, checked with patient @ 10:37am who stated that she was nervous and her throat felt tight. Patient was taken to a seperate room by this RN and clinic MD. O2, pulse ox and EpiPen available. Placed pulse ox on patient, O2 sats 98%. Patient continued to complain of throat feeling tight and she was visuably getting more nervous and stated her throat felt worse. Decision was made by this RN and Clinic Doc to adminster 0.3mg of Epipen and 911 was called @ approx 10:42am. Called patients daughter and explained what happened, sat with patient until squad arrived. Squad transported to ED.
Blurred vision, warm at injection site, burning sensation in chest and throat, vomiting, dizzy. Tx: BENADRYL, epi, IV with N.S. - doctor.
Defective gardasil 9 syringe. The finger flanges were found to be broken; CALLER ST ATES IT WAS RECEIVED WRAPPED IN BUBBLE WRAP IN A PLASTIC BAG, THERE WAS NOT A TRAY / NO CARTON; Cut themself while handling Gardasil 9; Cut themself while handling Gardasil 9; This spontaneous report was received from the office manager concerning a female patient of unknown age.   The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 13-JAN-2022, the finger flanges (all the way around) of a defective hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) syringe (lot # U008315, expiration date reported as 14-AUG-2023, but upon internal validation stablished as 15-AUG-2023) were found to be broken when the nurse practitioner was going to attach the needle to the syringe. The product was received wrapped in bubble wrap in a plastic bag, there was not a tray and no carton. An unknown staff member at the facility cut herself while handling the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) with the broken flange. The product was not administered to a patient. The outcome of the wound was not reported.  The causality assessment was not reported.
Sypmtoms: fever, chills, headache, muscle ache (especially backache), nausea.  Onset of symptoms occured approximately 19 hours after injection.  Sypmtoms lasted between 24-48 hours. Treatment of symptoms was tylenol and advil.
Breast feeding; rash on left ankle; Nausea; Light headedness; Arm soreness; Chills; Body aches and soreness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of NAUSEA (Nausea), DIZZINESS (Light headedness), PAIN IN EXTREMITY (Arm soreness), CHILLS (Chills) and PAIN (Body aches and soreness) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced NAUSEA (Nausea), DIZZINESS (Light headedness), PAIN IN EXTREMITY (Arm soreness), CHILLS (Chills) and PAIN (Body aches and soreness). On 04-Jan-2021, the patient experienced RASH (rash on left ankle). On an unknown date, the patient experienced BREAST FEEDING (Breast feeding). On 30-Dec-2020, NAUSEA (Nausea) and DIZZINESS (Light headedness) had resolved. On 31-Dec-2020, PAIN IN EXTREMITY (Arm soreness) had resolved. At the time of the report, CHILLS (Chills), PAIN (Body aches and soreness) and RASH (rash on left ankle) outcome was unknown and BREAST FEEDING (Breast feeding) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   Action taken with mRNA-1273 in response to the event is not applicable.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jan-2021: Additional event received; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Received VARIVAX 5-21-09, seen in office 5/23/09 arm, red, warm to touch for 2 days. 15 x 14 cm erythemas with 4 x 6 cm central induration and 5-6 2 mm papula.
Cellulitis, 5 1/2 x 5 1/2cm area of erythema to right upper thigh.
Given Tdap, PNEUMOVAX, Hep A. Two given in that (L) arm and documentation says (2) given in (R) arm. (I suspect this was a Tdap RXN superficial cellulitis patch approx. 12 cm x 14 cm.